Skip to main navigation Skip to search Skip to main content

Predictive factors for successful imatinib cessation in chronic myeloid leukemia patients treated with imatinib

  • Sung Eun Lee
  • , Soo Young Choi
  • , Ju Hee Bang
  • , Soo Hyun Kim
  • , Eun Jung Jang
  • , Ji Young Byeun
  • , Jin Eok Park
  • , Hye Rim Jeon
  • , Yun Jeong Oh
  • , Hyeoung Joon Kim
  • , Yeo Kyeoung Kim
  • , Joon Seong Park
  • , Seong Hyun Jeong
  • , Sung Hyun Kim
  • , Dae Young Zang
  • , Sukjoong Oh
  • , Dong Hoe Koo
  • , Hawk Kim
  • , Young Rok Do
  • , Jae Yong Kwak
  • Jeong A. Kim, Dae Young Kim, Yeung Chul Mun, Michael J. Mauro, Dong Wook Kim*
*Corresponding author for this work
  • The Catholic University of Korea
  • Chonnam National University
  • Ajou University
  • Dong-A University
  • Hallym University
  • Sungkyunkwan University
  • University of Ulsan
  • Keimyung University
  • Ewha Womans University
  • Oregon Health and Science University

Research output: Contribution to journal › Journal article › peer-review

Fingerprint

Dive into the research topics of 'Predictive factors for successful imatinib cessation in chronic myeloid leukemia patients treated with imatinib'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology